 |
|
Subject: method as recommended for its transparency pharm. Unless otherwise specified missing values including intermittent missing values and values missing in the main trial will be imputed using the Last Observation Carried Forward () method as recommended for its transparency in the FDA guidance .35 In the following section “end of trial” means a subject’s last end of trial visit excluding the follow-up visit.Подскажите, пожалуйста, как здесь лучше перевести "transparency"? |
| спасибо, не встречала раньше в качестве характеристики метода.. |
| You need to be logged in to post in the forum |